Leadership Overview
Servier has 5 executives leading key functions including operations, research, and institutional relations.
Driven by a commitment to patient well-being, Servier is an independent pharmaceutical company dedicated to developing innovative medicines and improving global health outcomes through its non-profit foundation governance.
Driven by a commitment to patient well-being, Servier is an independent pharmaceutical company dedicated to developing innovative medicines and improving global health outcomes through its non-profit foundation governance.
Leadership Roles at Servier
Ramadan Ashour - Driver for the CEO
Ramadan Ashour, the Driver for the CEO at Servier, ensures efficient and safe transportation for executive leadership. This role directly supports the operational continuity of the CEO's daily activities, facilitating timely engagement with internal teams and external stakeholders. Ashour's responsibilities include managing vehicle logistics and maintaining schedules to optimize executive travel. This function is critical for maintaining the swift decision-making processes that underpin Servier's global pharmaceutical operations. The executive's focus remains on providing reliable support, enabling the CEO to concentrate on strategic initiatives and the development of new medicinal products. Ramadan Ashour's contribution is integral to the seamless functioning of the executive office, supporting Servier's mission to create, test, and develop new treatments.
Pedro Crisanto - Chief Operating Officer, Research & Development (USA), Servier Pharmaceuticals
Pedro Crisanto, the Chief Operating Officer, Research & Development (USA), Servier Pharmaceuticals at Servier, spearheads the operational execution of research and development activities within the United States. This critical role involves managing the complex processes of creating, testing, and developing new medicinal products, aligning with Servier's global innovation strategy. Crisanto directs the US-based R&D teams, ensuring adherence to rigorous scientific standards and regulatory requirements. The Chief Operating Officer's focus is on optimizing the efficiency and effectiveness of the research centers, driving the advancement of novel therapeutic solutions. Pedro Crisanto's leadership ensures that Servier Pharmaceuticals maintains its competitive edge in drug development, contributing significantly to the company's mission of improving patient health worldwide. This operational leadership is fundamental to Servier's global manufacturing and packaging capabilities.
Varso Toppjian - Institutional President of Servier Do Brasil
Varso Toppjian, the Institutional President of Servier Do Brasil at Servier, leads the strategic direction and operational oversight for the company's Brazilian subsidiary. This executive role is crucial for expanding Servier's reach in the South American market, ensuring the effective distribution and accessibility of its medicinal products. Toppjian directs initiatives that align with Servier's global mission of developing innovative treatments and improving patient outcomes. The Institutional President fosters key relationships with healthcare providers, regulatory bodies, and local stakeholders to advance the company's objectives. Varso Toppjian's leadership ensures that Servier Do Brasil effectively implements the company's research, manufacturing, and packaging strategies within the region, reinforcing Servier's commitment to global health and its unique governance structure.
Antoine Anh - Chief of Staff
Antoine Anh, the Chief of Staff at Servier, directs strategic initiatives and operational alignment across the pharmaceutical company. This leadership position involves coordinating cross-functional teams to execute the company's research and development pipeline, ensuring new medicinal products move efficiently from creation to market. Anh's oversight extends to managing key projects and facilitating communication between executive leadership and global operational units. The Chief of Staff drives the implementation of Servier's non-profit foundation governance, reinforcing the company's commitment to patient well-being. By streamlining internal processes and fostering collaboration, Antoine Anh enhances Servier's capacity for innovation and its global manufacturing and packaging efforts. This role is pivotal in translating strategic objectives into tangible outcomes for Servier Pharmaceuticals.
Xavier Pernee - Responsible Information & Publicity
Xavier Pernee, the Responsible Information & Publicity at Servier, manages the strategic communication and public relations initiatives for the pharmaceutical company. This position is vital for disseminating information about Servier's advancements in creating, testing, and developing new medicinal products to both internal and external audiences. Pernee oversees the publicity efforts, ensuring accurate and compelling representation of the company's research centers and their contributions to global health. The Responsible Information & Publicity directs campaigns that highlight Servier's commitment to innovation and its role as an independent, non-profit foundation-governed entity. Xavier Pernee's expertise in communication is essential for building and maintaining Servier's reputation, supporting its mission to deliver life-changing treatments worldwide and reinforcing its global manufacturing presence.
Explore Leadership Teams in Manufacturing
BeOne Medicines is a global biotechnology company focused on developing next-generation cancer treatments through innovative research and cutting-edge therapies. The company is committed to making these treatments accessible to patients worldwide, emphasizing speed, equity, and affordability in delivering care. Guided by the principle that cancer knows no borders, BeOne Medicines operates with a global perspective, striving to expand the reach of life-saving therapies and improve outcomes for patients everywhere.
Company Leadership
MD
AA
YY
Zoetis discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, medicated feed additives that offer medicines to livestock; and other pharmaceutical products, which comprise allergy and dermatology, pain and sedation, antiemetic, reproductive, and oncology products. It markets to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company is headquartered in Parsippany, New Jersey.
Company Leadership KV
KK
RV
Abbott is a global healthcare company that develops and delivers a broad range of medical technologies, diagnostics, nutrition products, and branded generic medicines. The company is focused on improving health outcomes and helping people live healthier lives across all stages of life. Its mission centers on creating innovative solutions that address important medical needs, including chronic disease management, cardiovascular care, diabetes care, and pain management.
Company Leadership SB
JA

TriRx Pharmaceuticals is a contract development and manufacturing organization specializing in both non-sterile and sterile products, including animal health injectables and packaging solutions. The company offers a wide range of capabilities such as development and analytics, sterile and non-sterile manufacturing, and packaging services. With facilities located in Huntsville, Alabama, and Segré, France, TriRx aims to support customers' commercialization efforts across global markets. Their target clients include pharmaceutical companies looking for advanced solutions to bring their products to market.
Company Leadership RM
KL
JS
SH